A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer
Clinical trial NCT06692959 · TERMINATED
Trial details
- NCT number
- NCT06692959
- Sponsor
- University of Southampton
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-16
- Primary completion
- 2026-06-11
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.